STATE STREET CORP - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$850,140
-61.7%
794,523
-7.2%
0.00%
Q2 2023$2,218,506
-26.5%
856,566
+15.9%
0.00%
Q1 2023$3,016,556
-57.4%
739,352
-47.5%
0.00%
Q4 2022$7,073,692
-36.8%
1,409,102
+64.7%
0.00%
-100.0%
Q3 2022$11,191,000
+13.3%
855,575
+11.0%
0.00%0.0%
Q2 2022$9,877,000
-6.3%
770,442
+11.4%
0.00%0.0%
Q1 2022$10,545,000
-11.8%
691,506
+2.4%
0.00%0.0%
Q4 2021$11,961,000
-8.4%
675,380
+8.7%
0.00%0.0%
Q3 2021$13,057,000
+11.4%
621,163
+4.5%
0.00%0.0%
Q2 2021$11,726,000
-17.3%
594,618
+21.9%
0.00%0.0%
Q1 2021$14,177,000
+0.6%
487,682
+4.8%
0.00%0.0%
Q4 2020$14,093,000
+100.6%
465,203
+5.3%
0.00%
Q3 2020$7,027,000
-23.4%
441,700
-4.9%
0.00%
-100.0%
Q2 2020$9,172,000
+62.0%
464,626
+1.2%
0.00%
Q1 2020$5,660,000
-18.7%
459,052
+21.9%
0.00%
Q4 2019$6,965,000
+287.4%
376,673
+190.2%
0.00%
Q3 2019$1,798,000
+145.6%
129,820
+45.7%
0.00%
Q2 2019$732,00089,0950.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Column Group LLC 18,136,735$237,228,00052.50%
Ponoi II Management, LLC 1,298,908$16,990,00044.41%
Ponoi Management, LLC 1,298,908$16,990,00023.20%
Euclidean Capital LLC 746,674$9,766,0009.07%
StepStone Group LP 1,573,357$20,580,0002.93%
Logos Global Management LP 850,000$11,118,0001.37%
First Light Asset Management, LLC 955,505$12,498,0001.26%
GREAT POINT PARTNERS LLC 316,256$4,137,0001.00%
Rubric Capital Management LP 877,161$11,473,0000.58%
Avidity Partners Management LP 1,798,100$23,519,0000.48%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders